Anna Olechowska

Researchers assessed whether current metabolic parameters are inversely associated with cognitive functioning.

Reducing basal insulin delivery by 50%-80% 90 minutes before aerobic exercise better prevents hypoglycemia risk vs basal suspension or disconnection at exercise onset.

Menopausal hormone therapy may slow cognitive decline in postmenopausal women with mild cognitive impairment.

Romosozumab increased bone mineral density in postmenopausal women through increased bone formation and decreased bone resorption.

A recent study supports the clinical use of a combination of fasting glucose and HbA1c levels from a single blood sample to identify undiagnosed diabetes.

Higher fT3 levels, fT3:fT4 ratios, and second trimester isolated hypothyroxinemia during pregnancy are predictive markers of gestational diabetes.

Oral semaglutide 14 mg led to statistically significant improvement in hemoglobin A1c levels and weight loss in adults with type 2 diabetes.

Oral contraceptive use in women of reproductive age may increase the risk for lifetime asthma.

Younger patients treated with antipsychotics after experiencing a first episode of psychosis are at an increased risk for metabolic syndrome and cardiovascular disease.

Researchers examined whether menopausal symptoms, quality of life, and depression are related to arterial stiffness, a risk factor for cardiovascular disease.